'Too Big to Ban' WuXi AppTec Gains 100% on GLP 1 Chokehold WuXi AppTec's stock has surged by a staggering 100% in recent weeks, driven largely by its dominance of the lucrative GLP 1 market.
The Chinese biotech firm's rapid ascent has left many wondering how it managed to corner such a significant share of the industry.
WuXi AppTec's success is not merely a product of its own merits but also the result of a complex interplay between regulatory environment and patent disputes.